Diabetes Self-Management Education for Diabetes Mellitus, Type 2
Phase-Based Progress Estimates
Effectiveness
Safety
University of Michigan, Ann Arbor, MI
Diabetes Mellitus, Type 2+1 More
Diabetes Self-Management Education - BehavioralEligibility
18+
Male
What conditions do you have?
Select
Eligibility
18+
Male
What conditions do you have?
Select
Study Summary
This trial is looking to test the feasibility and acceptability of a diabetes self-management program for black men with type 2 diabetes. The purpose of this trial is to test the effectiveness of Diabetes Self-Management Education as a treatment for Diabetes Mellitus, Type 2. No patients in this trial will receive a placebo. Diabetes Self-Management Education has previously been approved by the FDA for a different condition, but this will be the first time it is being tested as a treatment for Diabetes Mellitus, Type 2.
Eligible Conditions
- Diabetes Mellitus, Type 2
Treatment Effectiveness
Effectiveness Progress
Other trials for Diabetes Mellitus, Type 2
Study Objectives
2 Primary · 7 Secondary · Reporting Duration: baseline, 3-months, 9-months, 15-months
baseline, 3-months, 9-months, 15-months
Change in Adherence to gender norms
Change in Blood Pressure
Change in Body Mass Index
Change in Depression
Change in Diabetes Quality of Life
Change in Diabetes Social Support
Change in Diabetes-Related Distress
Change in Hemoglobin A1c
Change in Regimen Adherence
Trial Safety
Safety Progress
Other trials for Diabetes Mellitus, Type 2
Trial Design
2 Treatment Groups
Control Group
1 of 2
Peer led diabetes self-management support (PLDSMS)
1 of 2
Active Control
Experimental Treatment
60 Total Participants · 2 Treatment Groups
Primary Treatment: Diabetes Self-Management Education · No Placebo Group · N/A
Peer led diabetes self-management support (PLDSMS)Experimental Group · 2 Interventions: Peer Led Diabetes Self-Management Support, Diabetes Self-Management Education · Intervention Types: Behavioral, Behavioral
Control Group
Behavioral
ActiveComparator Group · 1 Intervention: Diabetes Self-Management Education · Intervention Types: BehavioralTreatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Diabetes Self-Management Education
2016
N/A
~520
Trial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, 3-months, 9-months, 15-months
Closest Location: University of Michigan · Ann Arbor, MI
2022First Recorded Clinical Trial
24 TrialsResearching Diabetes Mellitus, Type 2
1012 CompletedClinical Trials
Who is running the clinical trial?
University of MichiganLead Sponsor
1,597 Previous Clinical Trials
6,328,281 Total Patients Enrolled
32 Trials studying Diabetes Mellitus, Type 2
4,673 Patients Enrolled for Diabetes Mellitus, Type 2
Jaclynn Hawkins, PhDPrincipal InvestigatorUniversity of Michigan, School of Social Work
Eligibility Criteria
Age 18+ · Male Participants · 1 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments